Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Perforated Appendicitis

moxifloxacin has been researched along with Perforated Appendicitis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Deans, KJ; Minneci, PC1
Aarnio, M; Grönroos, J; Haijanen, J; Hurme, S; Ilves, I; Laukkarinen, J; Löyttyniemi, E; Marttila, H; Mattila, A; Meriläinen, S; Nordström, P; Paajanen, H; Pinta, T; Rantanen, T; Rautio, T; Rintala, J; Salminen, P; Sävelä, EL; Savolainen, H; Sippola, S; Sippola, T; Tammilehto, V1
Hampel, B; Lippert, H; Muehlhofer, E; Reimnitz, P; Weiss, G1
Choudhri, S; Herrington, J; Malangoni, MA; Pertel, P; Song, J1

Trials

3 trial(s) available for moxifloxacin and Perforated Appendicitis

ArticleYear
Effect of Oral Moxifloxacin vs Intravenous Ertapenem Plus Oral Levofloxacin for Treatment of Uncomplicated Acute Appendicitis: The APPAC II Randomized Clinical Trial.
    JAMA, 2021, 01-26, Volume: 325, Issue:4

    Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Adult; Anti-Bacterial Agents; Appendectomy; Appendicitis; Drug Therapy, Combination; Ertapenem; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Moxifloxacin; Tomography, X-Ray Computed; Young Adult

2021
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).
    Journal of chemotherapy (Florence, Italy), 2009, Volume: 21, Issue:2

    Topics: Abdominal Abscess; Administration, Oral; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Appendicitis; Aza Compounds; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Peritonitis; Prospective Studies; Quinolines

2009
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.
    Annals of surgery, 2006, Volume: 244, Issue:2

    Topics: Abdominal Abscess; Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendicitis; Aza Compounds; Bacterial Infections; Cross Infection; Double-Blind Method; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Intestinal Perforation; Male; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Quinolines; Safety; Stomach Rupture; Treatment Outcome

2006

Other Studies

1 other study(ies) available for moxifloxacin and Perforated Appendicitis

ArticleYear
Evolving Issues in the Use of Antibiotics for the Treatment of Uncomplicated Appendicitis.
    JAMA, 2021, 01-26, Volume: 325, Issue:4

    Topics: Acute Disease; Anti-Bacterial Agents; Appendectomy; Appendicitis; Ertapenem; Humans; Levofloxacin; Moxifloxacin

2021